# A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks

> **NCT01098721** · PHASE2 · COMPLETED · sponsor: **Welichem Biotech Inc.** · enrollment: 61 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **DRUG:** WBI-1001

## Key facts

- **NCT ID:** NCT01098721
- **Lead sponsor:** Welichem Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2012-12-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01098721

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01098721, "A Safety/Efficacy Study of a Non-steroid, Topical Cream Treatment of Psoriasis Over 12-weeks". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01098721. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*